UBS AG - TETRALOGIC PHARMACEUTICALS C ownership

TETRALOGIC PHARMACEUTICALS C's ticker is TLOG and the CUSIP is 88165U109. A total of 23 filers reported holding TETRALOGIC PHARMACEUTICALS C in Q4 2013. The put-call ratio across all filers is - and the average weighting 0.6%.

Quarter-by-quarter ownership
UBS AG ownership history of TETRALOGIC PHARMACEUTICALS C
ValueSharesWeighting
Q3 2014$17,0000.0%4,056
+39.9%
0.00%
Q2 2014$17,000
+142.9%
2,900
+163.6%
0.00%
Q1 2014$7,000
-61.1%
1,100
-42.2%
0.00%
Q4 2013$18,0001,9020.00%
Other shareholders
TETRALOGIC PHARMACEUTICALS C shareholders Q4 2013
NameSharesValueWeighting ↓
Clarus Ventures, LLC 4,644,705$19,322,0007.71%
First Washington CORP 185,250$771,0000.44%
SPHERA FUNDS MANAGEMENT LTD. 194,200$808,0000.10%
KINGDON CAPITAL MANAGEMENT, L.L.C. 286,801$1,173,0000.05%
EMERALD ADVISERS, LLC 175,000$728,0000.04%
Pine River Capital Management L.P. 209,900$873,0000.01%
Alyeska Investment Group, L.P. 79,196$329,0000.01%
HighTower Advisors, LLC 66,514$277,0000.01%
Tower Research Capital LLC (TRC) 1,441$6,0000.00%
First Eagle Investment Management, LLC 114,456$476,0000.00%
View complete list of TETRALOGIC PHARMACEUTICALS C shareholders